Clinical Trial Update: Perioperative Treatment of Resectable Liver Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating perioperative treatment for resectable liver metastases from colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Snippet

Sponsor: University of Regensburg | Conditions: Colon Cancer Liver Metastasis | Phase 2 | Status: WITHDRAWN